Search

everythinglearnresearchcommunity

for

Search:↓

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

COVID-19 affected Black communities more in Oakland County, MI, but didn't increase death rates.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Androgen-driven traits don't predict prostate cancer recurrence.

Tamsulosin increases the risk of floppy iris during eye surgery.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

The link between anabolic agents and colorectal cancer risk is unclear.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

Dutasteride for hair loss might increase the risk of a rare stroke type.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Lack of vitamin D receptor increases skin tumor risk by boosting hedgehog signaling.

Finasteride does not increase the risk of depression or suicide.

Inflammatory diets may increase the risk and severity of alopecia areata.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.